Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004198 |
ID: | TCMBANKHE004198 |
植物拉丁名: |
|
功能与主治: | See Magnolia liliflora./See Magnolia liliflora. |
药用植物名: | 望春玉兰 |
药用部位: | flower bud |
TCM_ID_id: | 2849 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000007 | eudesmin | C22H26O6 | 386.4 g/mol | COC1=C(C=C(C=C1)C2C3COC(C3CO2)C4=CC(=C(C=C4)OC)OC)OC | |
| TCMBANKIN006355 | lirioresinol b dimethyl ether | 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-, (1S,3aR,4S,6aR)-; C24H30O8; ( )-O,O-Dimethyllirioresinol B; 1H,3H-Furo(3,4-c)furan, 3aalpha,4,6,6aalpha-tetrahydro-1alpha,4alpha-bis(3,4,5-trimethoxyphenyl)-; ( )-Yangabin; Yangabin; 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5)-trimethoxyphenyl)-, 1alpha,3aalpha,4alpha,6aalpha)-; CCRIS 8944; Lirioresinol B dimethyl ether; O,O-Dimethyllirioresinol B; lirioresinol b dimethyl-ether; Lirioresinol B, dimethyl-; LS-70759; (1S-(1alpha,3aalpha,4alpha,6aalpha))-isomer of epiyangambin; Lirioresinol B, O,O-dimethyl- | C24H30O8 | 446.5 g/mol | COC1=CC(=CC(=C1OC)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC)OC |
| TCMBANKIN032279 | aschantin | C22H24O7 | 400.4 g/mol | COC1=CC(=CC(=C1OC)OC)C2C3COC(C3CO2)C4=CC5=C(C=C4)OCO5 | |
| TCMBANKIN033787 | denudatine | C22H33NO2 | 343.5 | CCN1CC2(CCCC34C2CC(C31)C56C4C(C(CC5)C(=C)C6O)O)C | |
| TCMBANKIN034918 | magnolin | C23H28O7 | 416.5 g/mol | COC1=C(C=C(C=C1)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC)OC)OC | |
| TCMBANKIN036815 | berberine | berberine ; isoquinoline alkaloid | C20H18NO4 | 337 | C12=N(C([H])([H])C([H])([H])c(c([H])c(OC([H])([H])O3)c3c4[H])c14)C([H])=C(C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C5[H])C5=C2[H] |
| TCMBANKIN036902 | magnolol | UPCMLD-DP037:001; UNII-001E35HGVF; 001E35HGVF; TR-031540; FT-0628104; SR-01000758206-3; AN-15430; 2'-Bichavicol; NSC 293099; MLS001048917; STK801955; KS-000009BG; ZINC00001645; [1,1'-Biphenyl]-2,2'-diol, 5,5'-di-2-propenyl-; 5,5'-bis(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol; HMS3651O18; ZINC1645; PubChem19035; DS-1284; CTK1G9448; ST24029219; NCGC00161609-01; 2-(2-hydroxy-5-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol; 5,5'-Di-2-propenyl-[1,1'-biphenyl]-2,2'-diol; HY-N0163; BN0720; 2-(2-hydroxy-5-prop-2-enylphenyl)-4-prop-2-enylphenol; MFCD00016658; SMP2_000086; SCHEMBL132477; 5,5'-Diallyl-2,2'-dihydroxybiphenyl; (1,1'-Biphenyl)-2,2'-diol, 5,5'-di-2-propenyl-; 3r5n; BC205200; Magnolol, European Pharmacopoeia (EP) Reference Standard; NSC293099; Magnolol, >=95% (HPLC), from plant; ACN-035415; SMR000387108; CM0085; Magnolol; NCGC00161609-02; magnolol ; MCULE-1351244567; AB0016717; VVOAZFWZEDHOOU-UHFFFAOYSA-N; 4-allyl-2-(5-allyl-2-hydroxy-phenyl)phenol; 2-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol; 5,5'-Diallyl-[1,1'-biphenyl]-2,2'-diol; 2-(2-oxidanyl-5-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol; 528-43-8; 4-allyl-2-(5-allyl-2-hydroxyphenyl)phenol; HMS2269N09; Dehydrodichavicol; AC1Q7B1V; 4CN-0760; D3971; 5,5′-Diallyl-2,2′-biphenyldiol; BBL027818; s2321; 5,5'-Diallylbiphenyl-2,2'-diol; NSC-293099; KB-279770; CHEMBL180920; CCG-208588; AJ-08064; S-2836; 5,5'-Diallyl-2,2'-biphenyldiol; 5,5'-di(prop-2-en-1-yl)biphenyl-2,2'-diol; SR-01000758206; HSDB 7686; DTXSID0044076; AIDS-002239; BR-72952; CHEBI:6643; SC-25620; J10186; 5,5;-Diallyl-[1,1;-biphenyl]-2,2;-diol; M3445_SIGMA; UPCMLD-DP037; 528M438; BDBM78304; I01-2281; O906; Q-100598; AX8016874; LS-44356; AIDS002239; 2,2'-Bichavicol; BG00615874; Kopnolia; AC-931; N1359; SR-01000758206-4; AK-72952; MolPort-002-507-434; BB_NC-1463; Bio-0675; BRD-K26168087-001-01-4; RTR-031540; AKOS005266409; ZB000381; REGID_for_CID_72300; cid_72300; C-16714; C10651; AC1L2HT7; SY016075; CC-30123; CJ-00060; CS-5021 | C18H18O2 | 266.334 | C([H])([H])=C([H])C([H])([H])c1c([H])c([H])c(O[H])c(c2c([H])c(C([H])([H])C([H])=C([H])[H])c([H])c([H])c2O[H])c1[H] |
| TCMBANKIN042177 | fargesone a | C21H24O6 | 372.4 g/mol | CC1C(OC2C1(C(=CC(=O)C2CC=C)OC)OC)C3=CC4=C(C=C3)OCO4 | |
| TCMBANKIN042284 | biondinin c | C19H24O3 | 300.4 g/mol | CC1(C2CCC1(C(C2)OC(=O)C=CC3=CC=C(C=C3)O)C)C | |
| TCMBANKIN042998 | fargesin | C21H22O6 | 370.4 g/mol | COC1=C(C=C(C=C1)C2C3COC(C3CO2)C4=CC5=C(C=C4)OCO5)OC | |
| TCMBANKIN044238 | biondinin d | C19H24O3 | 300.4 g/mol | CC1(C2CCC1(C(C2)OC(=O)C=CC3=CC=C(C=C3)O)C)C | |
| TCMBANKIN045425 | biondinin e | C23H30O7 | 418.5 g/mol | COC1=C(C=C(C=C1)C2C(C(CO2)C(C3=CC(=C(C=C3)OC)OC)OC)CO)OC | |
| TCMBANKIN046057 | Biondinin B | 404.5 g/mol | |||
| TCMBANKIN048075 | lithocarpdiol | C31H52O3 | 472.7 g/mol | CC(C)C1(CCC(CO1)C2CCC3(C2(CCC45C3CCC6C4(C5)CCC(C6(C)C)O)C)C)CO | |
| TCMBANKIN048392 | alpha-eudesmol | 92480-60-9; 2-[(2R,4aR,8aR)-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1H-naphthalen-2-yl]propan-2-ol; 75684-39-8; C09663; 473-16-5; α-eudesmol; 2-Naphthalenemethanol, 1,2,3,4,4a,5,6,8a-octahydro-alpha,alpha,4a,8-tetramethyl-, (2R,4aR,8aR)-; alpha-eudesmol | C15H26O | 222.366 | [C@@]1([H])(C(O[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[C@@]([H])(C(C([H])([H])[H])=C([H])C([H])([H])C2([H])[H])[C@@]2(C([H])([H])[H])C([H])([H])C1([H])[H] |
| TCMBANKIN049873 | biondinin a | C21H26O6 | 374.43 | COC1=C(C=C(C=C1)C2C(C3=CC(=C(C=C3CCCO2)OC)O)CO)OC | |
| TCMBANKIN058200 | buddlenoid A | buddl-enoid A;biondnoid i | C30H26O13 | 594.5 g/mol | C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=C(C4=O)O)C5=CC=C(C=C5)O)O)O)O)O)O |
| TCMBANKIN059963 | naphthalene,1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-,(1S-cis)-;Naphthalene, 1, 2, 3, 5, 6, 8a-hexahydro-4, 7-dimethyl-1-(1-methylethyl)-,(1S-cis);δ-cadinol | C15H24;C10H18 | 204.35 g/mol | CC1=CC2C(CCC(=C2CC1)C)C(C)C | |
| TCMBANKIN060032 | alpha-Eudesmol | C15H26O | 222.37 | CC1=CCCC2(C1CC(CC2)C(C)(C)O)C | |
| TCMBANKIN061503 | pinoresinol dimethyl ether | AK554305; (1S,3aR,4S,6aR)-1,4-bis(3,4-dimethoxyphenyl)hexahydrofuro[3,4-c]furan; AC1Q70YM; BB_NC-1494; SCHEMBL12427086; MolPort-002-507-449; 1H,3H-Furo(3,4-c)furan, 1,4-bis(3,4-dimethoxyphenyl)tetrahydro-, (1R-(1alpha,3aalpha,4alpha,6aalpha))-; BG00731937; CHEBI:23; (1s,3ar,4s,6ar)-1,4-bis(3,4-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan; CHEMBL519099; UNII-3TPV0HJ9B0; 3TPV0HJ9B0; MCULE-6571787081; NSC 35476; AC1L2JAN; ZINC1668160; AKOS002141813; CTK6J7000; (3S,3aR,6S,6aR)-3,6-bis(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan; C10561; (+)-Eudesmin; Pinoresinol dimethyl ether; Pinoresinoldimethylether; 29106-36-3; (1s,3ar,4s,6ar)-1,4-bis(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan; MCULE-2307890111; NCGC00380478-01!(3S,3aR,6S,6aR)-3,6-bis(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan; Eudesmine; 526-06-7; (+)-pinoresinol dimethyl ether; pinoresinol dimethylether; SureCN12427086;(+ )-pinoresinol dimethyl ether;(+)-Eudesmin | C22H26O6 | 386.4 g/mol | COC1=C(C=C(C=C1)C2C3COC(C3CO2)C4=CC(=C(C=C4)OC)OC)OC |
| TCMBANKIN061505 | l-planinin | kobusin; ACon1_001273; MEGxp0_001295; 5-[(1S,3aR,4S,6aR)-4-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-1,3-benzodioxole; kobusin; 36150-23-9; fargesin; demethoxyaschantin | C21H22O6 | 370.4 g/mol | COC1=C(C=C(C=C1)C2C3COC(C3CO2)C4=CC5=C(C=C4)OCO5)OC |
| TCMBANKIN061673 | jatrorrizine | Jatrorrhizine, iodide; 2,9,10-trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-3-ol iodide; iatrorrhizine; JATRORRHIZINE IODIDE; jatrorhizinc; CHEMBL1990190; NSC-93137; AC1NURFL; Q-100433; Ambap3621-38-3; 7,8,13,13alpha-Tetradehydro-3-hydroxy-2,9,10-trimethoxyberbinium; jatrorrhizine; 1168-00-9; KB-78657; NSC93137; jatrorrhizine; jatrorrhizine | C20H20NO4+ | 338.4 g/mol | COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)O)OC)OC |
| TCMBANKIN061674 | palmatin;palmatine | V1557; 5,6-Dihydro-2,3,9,10-tetramethoxydibenzo(a,g)quinolizinium hydroxide; Calystigine; Palmatine chloride; palmatine ; 6771L5MN8S; UNII-6771L5MN8S; MolPort-039-138-801; 3486-67-7 (Parent); Palmatine hydroxide; 131-04-4; BG01657711; AC1L43OM; Palmatinium hydroxide; LS-61262; DTXSID60156830; 7,8,13,13a-Tetradehydro-2,3,9,10-tetramethoxyberbinium hydroxide; Dibenzo(a,g)quinolizinium, 5,6-dihydro-2,3,9,10-tetramethoxy-, hydroxide; 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium hydroxide; AS-17724 | C21H22NO4+ | 352.4 g/mol | COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC |
| TCMBANKIN061675 | berberime | berberine ; isoquinoline alkaloid; berberine | C20H18NO4+ | 336.4 g/mol | COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC |
| TCMBANKIN061784 | lirioresinol b dimethyl ether | 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-, (1S,3aR,4S,6aR)-; C24H30O8; ( )-O,O-Dimethyllirioresinol B; 1H,3H-Furo(3,4-c)furan, 3aalpha,4,6,6aalpha-tetrahydro-1alpha,4alpha-bis(3,4,5-trimethoxyphenyl)-; ( )-Yangabin; Yangabin; 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5)-trimethoxyphenyl)-, 1alpha,3aalpha,4alpha,6aalpha)-; CCRIS 8944; Lirioresinol B dimethyl ether; O,O-Dimethyllirioresinol B; lirioresinol b dimethyl-ether; Lirioresinol B, dimethyl-; LS-70759; (1S-(1alpha,3aalpha,4alpha,6aalpha))-isomer of epiyangambin; Lirioresinol B, O,O-dimethyl-; (- )-lirioresinol B; ACon1_001856; (1R,3aR,4S,6aR)-1,4-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan; MEGxp0_001363; CTK4E6827; DTXSID10175733; SCHEMBL17385618; AC1L4ZYE; (1r,3ar,4r,6ar)-1,4-bis(3,4,5-trimethoxyphenyl)tetrahydro-1h,3h-furo[3,4-c]furan; 1H,3H-Furo(3,4-c)furan, tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-,(1R,3aR,4R,6aR)-; Diayangambin; (+)-Diayangambin; AC1Q70YI; (3R,3aR,6R,6aR)-3,6-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan; Tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-(1R)-1alpha,3abeta,4alpha,6abeta-1H,3H-furo(3,4-c)furan; 21453-68-9; ZINC31477287; yangambin; C10894; ZINC04098936; (1S,3aR,4S,6aR)-1,4-bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan; 13060-14-5; Yangambin; diayangambin | C24H30O8 | 446.5 g/mol | COC1=CC(=CC(=C1OC)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab